Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat for prevention of cisplatin-induced nephrotoxicity
PACTR202509466836654Phase 1Completed
- Sponsor
- Basma Samir Clinic
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of febuxostat, sponsored by Basma Samir Clinic. Started Mar 2023; status: completed.
02
Drugs
febuxostat
Beyond the preview
Go deeper on PACTR202509466836654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509466836654.